Bioelectronics Corp (BIEL)

[jamesonkh]

BIEL = Most Popular Research Article in Pain Management in 2017, was a Short Communication entitled, ‘An over-the-counter central sensitization therapy: a chronic back pain registry study of pain relief, medication use and their adverse effects’. This collaborative effort came from researchers at Duke University (NC, USA), BioElectronics Corporation (MD, USA) and Binghamton University (NY, USA). The aim of this research was to determine the effectiveness of the ActiPatch medical devices in reducing chronic back pain over a 7-day trial. The authors concluded that it is an effective intervention for the majority of subjects for treating chronic back pain, without the known side-effects associated with medications. They do however note that further investigation through randomized clinical trials is required.

Future Medicine